Skip to content
TickerMagic

Sree Rayalaseema Hi-Strength Hypo Limited

SRHHYPOLTDNSEBasic Materials
₹528.5
-4.25 (-0.80%) · EOD 2026-11-20

Our verdict

Buy

Valuation (94/100) does the heavy lifting; financial trend (19/100) is the drag.

Buy zoneHealth A
Quality 54Momentum 72Value 94Trend 19The Spark ↓

Our fair value

Undervalued by 53%
₹807.15up 52.72%
Price ₹529Range ₹388 – ₹1,057

Buy-below (20% margin of safety): ₹645.72

The bottom line

Our blended model reads Sree Rayalaseema Hi-Strength Hypo Limited as a Buy at 63/100. At ₹528.5 it trades below our blended DCF and relative-multiples fair value of ₹807.15, about 53% upside to that estimate — we read it as undervalued by 53%. On 9.3x trailing earnings it sits cheaper than the Basic Materials median of about 22.2x. The price is about 16% below its 52-week high of ₹627.7 and 38% above the low of ₹381.77. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9. It clears 9 of 13 investability checks, with durability 54, valuation 87 and momentum 72 on our 0–100 scales.

Analysis by Ankit Sharma · TickerMagic's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.

Intrinsic value
Our fair value
₹807.15up 52.72%
Undervalued by 53%
Price ₹528.5Range ₹388.07–₹1,057
DCF + relative blendmedium confidence

With a 20% margin of safety, our buy-below price is ₹645.72.

1-year price

EOD · 2026-11-20
1D
down 0.80%
1W
down 0.07%
1M
up 3.11%
3M
up 9.12%
6M
up 5.43%
1Y
—

52-week range

-15.80% from the 52-week high.

Trend check
Above 50-DMA₹527Above 200-DMA₹492

Price above both moving averages reads as an intact uptrend; below both, the trend is against you.

Verdict pillars

Buy63
A
Financial health 100/100
Altman Z 5.9 · Safe zone

Piotroski F-score 5/9 — quality of earnings & balance sheet.

Our scores

Durability54
Valuation87
Momentum72

Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.

Investability checklist

Passed 9 of 13 checks
Each check screens one fundamentals, valuation or trend signal.
  • Fail: ROE above 15%: 9.4%
  • Pass: Low debt (D/E < 0.5): 0.01x
  • Pass: Positive free cash flow
  • Fail: Revenue growth > 10%: 2%
  • Fail: Earnings growing: -17%
  • Pass: Net margin ≥ 10%: 13.5%
  • Pass: Current ratio > 1.5: 10.55
  • Pass: Below our fair value
  • Pass: Margin of safety ≥ 20%
  • Pass: Above 200-day average
  • Pass: Above 50-day average
  • No data: Positive 1-year return
  • Pass: Altman Z in safe zone: Z 5.9
  • Fail: Piotroski ≥ 7: 5/9

Quarterly results

Revenue · 4Q2017
₹129 Cr
Net profit
₹1 Cr
Margin
1%
3Q2017
4Q2017
Revenue Net profitLatest revenue QoQ +3%

Shareholding

  • Promoter68.6%
  • Institutions0.0%
  • Public & other31.4%

Promoter holding via insider stake; institutional via reported holdings.

Key fundamentals

Market cap
₹848 Cr
P/E ratio
9.3
P/B ratio
0.84
EPS (TTM)
₹53.28
ROE
9.4%
Debt / Equity
0.01x
Profit margin
13.5%
Free cash flow
₹42 Cr
52-week high
₹627.7
-15.80% from high
52-week low
₹381.77
Dividend yield
0.6%
Beta
0.42
SWOT snapshot

Bull case vs bear case

Bull case

Strengths

  • Lightly leveraged balance sheet.
  • Financially solid — Altman Z 5.9.

Opportunities

  • Trading in our value buy zone versus sector peers.
  • Trades ~53% below our estimated fair value.

Bear case

Threats

  • Earnings contracting year on year.

About Sree Rayalaseema Hi-Strength Hypo Limited

Sree Rayalaseema Hi-Strength Hypo Limited manufactures and sells industrial chemicals in India across three business segments: chemical manufacturing, power generation, and coal trading. The company produces acids including sulphuric, chlorosulphonic, hydrochloric, and monochloro acetic; chlorine-based compounds such as purichlor, chloramine, and sodium dichloroisocyanurate; and specialty chemicals including aluminum sulphate, sodium methoxide, hydrogen gas, and water treatment products.

Sree Rayalaseema Hi-Strength Hypo Limited — frequently asked questions

Is Sree Rayalaseema Hi-Strength Hypo Limited a buy, hold or sell?

TickerMagic currently rates Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD) a Buy, based on a blended score of 63/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.

What is Sree Rayalaseema Hi-Strength Hypo Limited's fair value?

Our blended DCF and relative-valuation model estimates Sree Rayalaseema Hi-Strength Hypo Limited's fair value at about ₹807.15, versus a current price of ₹528.5 — roughly 53% upside. On that basis the stock looks undervalued by 53%.

Is Sree Rayalaseema Hi-Strength Hypo Limited financially healthy?

Sree Rayalaseema Hi-Strength Hypo Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9.

How has Sree Rayalaseema Hi-Strength Hypo Limited's share price performed?

Sree Rayalaseema Hi-Strength Hypo Limited is up 9% over three months, and last traded at ₹528.5. Past performance doesn't predict future returns.

Our verdict, fair value, financial-health and checklist are TickerMagic's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.